Weekly Policy Blog: PDAB Moves Two More Drugs to Upper Payment Limit Rulemaking Process

On July 3, the Colorado Prescription Drug Affordability Board (PDAB or Board) voted to initiate the upper payment limit (UPL) rulemaking process for two more drugs, Stelara and Cosentyx, after deeming...

Learn More

Fitzsimons Innovation Community Master Plan: Holistic. People-Focused. Community-Forward.

A conversation with Fitzsimons Innovation Community partner and Master Plan creator, Tryba Architects. By: Fitzsimons Innovation Community In creating the plan for a 184-acre innovation campus, Fitzsi...

Learn More

Weekly Policy Blog: Urge Congress to Reauthorize the Rare Pediatric Disease Priority Review Voucher (PPRV) Program  

CBSA and BIO urge you to reach out to Senator Hickenlooper to encourage his support of S.4583, a bill that would reauthorize the rare pediatric disease priority review voucher (PPRV) program before it...

Learn More

Weekly Policy Blog: CBSA Policy News Roundup—BIO International Convention and Prescription Drug Affordability Events 

This past week, the CBSA team represented our community and shared our expertise on prescription drug affordability at the BIO International Convention and through a series of virtual events:  El...

Learn More

Weekly Policy Blog: EPA, FDA, and USDA Release Joint Regulatory Plan for Biotechnology

CBSA and our partners at Biotechnology Innovation Organization (BIO) welcome the joint plan that the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), and the U....

Learn More

Bringing Life Sciences Innovators Home to Colorado

New eBook helps health innovators choose the right location for growth. By: Fitzsimons Innovation Community Fitzsimons Innovation Community is proud to present a new resource for life sciences compani...

Learn More

Boettcher Foundation Awards $2 Million to Colorado’s Leading Biomedical Researchers

Foundation Marks 15th Year with the 2024 Class of Boettcher Investigators DENVER, May 22, 2024 — Boettcher Foundation announces its 2024 Class of Boettcher Investigators today, eight leading Colorado...

Learn More

Weekly Policy Blog: LDT Final Rule Published 

The U.S. Food and Drug Administration (FDA) published a final rule overhauling its approach to the regulation of laboratory developed tests (LDTs) on May 6, 2024. The final rule, which is largely simi...

Learn More

CBSA Congratulates May 2024 Advanced Industries Accelerator Grant Recipients

Colorado Office of Economic Development and International Trade (OEDIT) has announced the newest recipients of state-funded Advanced Industries Accelerator Grants! Colorado BioScience Association cong...

Learn More

Weekly Policy Blog: Colorado’s 2024 Legislative Session Wraps Up  

Colorado’s 2024 legislative session, the Second Regular Session of the 74th General Assembly, concluded on May 8, the 120th day of session. During the final weeks of session, the Colorado BioScience A...

Learn More